J&J to discontinue HIV vaccine trial

(Reuters) - Johnson & Johnson said on Wednesday the company and its partners will discontinue the late-stage trial of an HIV vaccine after it was found ineffective at preventing infections.

(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)